Combination therapies of tamoxifen and trifluoperazine have shown to be effective on treatment of sporadic and NF1-associated MPNST, suggesting the quick repurposing of these drugs for clinical and prophylactic uses. Here, NF1 is linked to malignant peripheral nerve sheath tumor.